Skin Conditioning
TRANEXAMOYL DIPEPTIDE-35
Safety score · 0–100
Good
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A dipeptide derivative of tranexamic acid used to even tone and reduce dark spots. Skin-level safety is benign; tranexamic acid's prescription status applies to oral/IV doses, not cosmetic concentrations.
Function
Skin benefits
- Targeted brightening
- Tranexamic-acid-derived tone evening
- Dipeptide signalling support
- Well tolerated topically
Known concerns
- Systemic tranexamic acid is prescription-only (not relevant topically)
- Limited independent cosmetic clinical data
- Rare peptide allergy
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related skin conditionings
Check your shelf
Find TRANEXAMOYL DIPEPTIDE-35 in your products.
Scan any cosmetic product with LuxSense to see if it contains TRANEXAMOYL DIPEPTIDE-35 and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.